Analysis of drug resistance in HIV protease
Abstract Background Drug resistance in HIV is the major problem limiting effective antiviral therapy. Computational techniques for predicting drug resistance profiles from genomic data can accelerate the appropriate choice of therapy. These techniques can also be used to select protease mutants for...
Main Authors: | Shrikant D. Pawar, Christopher Freas, Irene T. Weber, Robert W. Harrison |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12859-018-2331-y |
Similar Items
-
Evolution of drug resistance in HIV protease
by: Dhara Shah, et al.
Published: (2020-12-01) -
HIV Protease: Historical Perspective and Current Research
by: Irene T. Weber, et al.
Published: (2021-05-01) -
Molecular Basis for Drug Resistance in HIV-1 Protease
by: Celia A. Schiffer, et al.
Published: (2010-11-01) -
HIV-1 Protease: Structural Perspectives on Drug Resistance
by: Irene T. Weber, et al.
Published: (2009-12-01) -
Impacts of drug resistance mutations on the structural asymmetry of the HIV-2 protease
by: Pierre Laville, et al.
Published: (2020-06-01)